Licensed Practical Nurse in Mesquite, TX Accepting Medicare

6 Licensed Practical Nurse nurses found. Showing 1 - 6

Athena Nwoko, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2028 Norcross Dr, Mesquite, TX 75149 Phone: 214-466-0864

Echo Johnson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4940 Kingfisher Ln, Mesquite, TX 75181 Phone: 469-855-0612

Mrs. Erica Douglas Woodkins, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2007 Nectar Dr, Mesquite, TX 75149 Phone: 214-315-4383

Yana Dosha Lee, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 508 Sandpiper Ln, Mesquite, TX 75149 Phone: 906-691-5640

Bernadetta Karanja, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1429 Jessica Ln, Mesquite, TX 75149 Phone: 214-235-3589

Sara Bonita Smith, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 909 Us Highway 80 E Apt 5305, Mesquite, TX 75150 Phone: 469-540-2376

News Archive

Scientists discover important neural mechanism underlying dyslexia

To participate successfully in life, it is important to be able to read and write. Nevertheless, many children and adults have difficulties in acquiring these skills and the reason is not always obvious. They suffer from dyslexia which can have a variety of symptoms. Thanks to research carried out by Bego-a D-az and her colleagues at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig, a major step forward has been made in understanding the cause of dyslexia.

Researchers analyze similarities and differences of CT features between heart failure and COVID-19

In a new publication from Cardiovascular Innovations and Applications; Zhaowei Zhu, Jianjun Tang, Xiangping Chai and colleagues from Central South University, Changsha, Hunan, China analyse the similarities and differences of CT features between COVID-19 pneumonia and heart failure.

Chemotherapy destabilizes gut microbiome in cancer patients

New research in BMC Cancer has shown myelosuppressive chemotherapy destabilizes gut microbiome in patients with solid organ cancers.

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of a Phase 3 clinical trial, known as PERSIST-2, which will evaluate pacritinib, a novel, investigational JAK2/FLT3 inhibitor, in patients with myelofibrosis whose platelet counts are less than or equal to 100,000 per microliter (uL).

Read more Medical News

› Verified 8 days ago